IPCA Laboratories
Swapnil Jangam is a skilled Regulatory Affairs professional with extensive experience in the pharmaceutical industry. Currently serving as a Regulatory Affairs Officer - Formulations at Ipca Laboratories Limited since November 2024, Swapnil previously worked at Medley Pharmaceuticals Ltd as an Assistant in Regulatory Affairs from November 2022 to November 2024, where responsibilities included assisting in dossier creation and preparing documents for eCTD submissions. Swapnil began a career in Regulatory Affairs as an intern at Bharati Vidyapeeth while pursuing a Master of Pharmacy in Regulatory Affairs from October 2021 to October 2023, complementing an earlier Bachelor of Pharmacy degree obtained from Mumbai Educational Trust in January 2021.
Previous companies
This person is not in any teams
This person is not in any offices
IPCA Laboratories
3 followers
Ipca Laboratories Limited is engaged in pharmaceuticals business. The Company is a manufacturer and supplier of over 10 active pharmaceutical ingredients (APIs). It offers APIs, such as atenolol, hydroxychloroquine sulfate, morantel citrate, pyrantel pamoate and zaltoprofen. It offers brands, such as Zerodol, Lariago, HCQS Perinorm, Rapither, Tenoric, Lumerax, Etova, Malirid and Folitrax. Its 3c division focuses on cardiovascular and anti-diabetic markets. Its 3d division is focused on cardio-diabetic market. The Company's activa division serves the rheumatology market. Its altus division caters to the needs of intensivists, both surgical and non-surgical. Its Bionova division's focus area is dermatology. Its dynamix division focuses on cardiovascular, gastro-intestinal, anti-bacterial, pain management and respiratory sectors. It hycare division caters to the needs of cardiologists and diabetologists. Its divisions also include innova, intima, pain management, pharma and uro sciences.